U.S. markets closed

AdaptHealth Corp. (AHCO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
23.62+0.43 (+1.85%)
At close: 04:00PM EDT
23.97 +0.35 (+1.48%)
After hours: 05:55PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close23.19
Bid19.22 x 1400
Ask30.00 x 1200
Day's Range23.02 - 23.68
52 Week Range11.40 - 28.75
Avg. Volume1,670,556
Market Cap3.177B
Beta (5Y Monthly)0.66
PE Ratio (TTM)28.12
EPS (TTM)0.84
Earnings DateNov 02, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est27.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
57% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for AHCO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AdaptHealth Corp.
    Daily – Vickers Top Insider Picks for 08/12/2022The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • Benzinga

    AdaptHealth Shares Fall As Q2 Profits Come Below Expectation, Reaffirms Annual Guidance

    AdaptHealth Corp (NASDAQ: AHCO) delivered Q2 revenue of $727.6 million, +17.9% Y/Y, beating the consensus of $724.22 million. Adjusted EBITDA reached $150 million, +1.8% Y/Y. The company said that Q2 revenue and Adjusted EBITDA are consistent with internal expectations as it continues to overcome challenges resulting from industry shortages of CPAP equipment. On a sequential basis, the adjusted EBITDA margin increased 110 basis points to 20.6%, as the company continues to manage through the infl

  • Motley Fool

    AdaptHealth Corp. (AHCO) Q2 2022 Earnings Call Transcript

    It is now my pleasure to introduce your host, Chris Joyce. In a moment, we'll have some prepared comments from Steve Griggs, chief executive officer of AdaptHealth; Josh Parnes, president of AdaptHealth; and Jason Clemens, chief financial officer of AdaptHealth.

  • Zacks

    AdaptHealth Corp. (AHCO) Q2 Earnings and Revenues Miss Estimates

    AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -35.71% and 0.17%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?